We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Calls Out Korean Manufacturer Over Contamination Concerns
FDA Calls Out Korean Manufacturer Over Contamination Concerns
An FDA inspection of Korean sterile OTC drug manufacturer Hanlim Pharm in January turned up multiple failures to follow procedures for preventing product contamination.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor